EU agency record confirming Denmark uses a risk-based (maternal HBsAg status) hepatitis B birth dose rather than a universal one — the model the December 2025 ACIP vote moved the U.S. toward. Also lists historical program changes (PCV7 in 2007, HPV for 12-year-old girls from 2009, boys from 2019).
Babies born to a mother infected with hepatitis B will be offered a first vaccine dose at birth simultaneously with HepB immunoglobulin.
EU agency record confirming Denmark uses a risk-based (maternal HBsAg status) hepatitis B birth dose rather than a universal one — the model the December 2025 ACIP vote moved the U.S. toward. Also lists historical program changes (PCV7 in 2007, HPV for 12-year-old girls from 2009, boys from 2019).